Loading chat...

TN HB2246

Bill

Status

Introduced

2/2/2026

Primary Sponsor

Chris Hurt

Click for details

Origin

House of Representatives

114th General Assembly

AI Summary

  • Physicians may perform stem cell therapies not approved by the FDA for orthopedics, wound care, or pain management, provided stem cells are obtained from FDA-registered facilities with certification from organizations like the National Marrow Donor Program or American Association of Tissue Banks

  • Advertisements for stem cell therapy must include a required notice stating the treatment is not FDA-approved, and physicians must obtain signed informed consent forms disclosing the experimental nature, risks, and alternatives

  • Stem cell therapy explicitly excludes the use of cells or tissues derived from a fetus or embryo after an abortion; intentionally performing such treatment or research constitutes a Class E felony

  • Sale, manufacture, or distribution of computer products created using human cells, tissues, or cellular tissue-based products is also classified as a Class E felony

  • Takes effect July 1, 2026, with rulemaking authority granted to the Board of Medical Examiners and Board of Osteopathic Examination effective immediately upon passage

Legislative Description

AN ACT to amend Tennessee Code Annotated, Title 63 and Title 68, relative to stem cell therapies.

Health Care

Last Action

Placed on s/c cal Health Subcommittee for 3/18/2026

3/11/2026

Committee Referrals

Health Subcommittee3/4/2026
Health2/5/2026

Full Bill Text

No bill text available